Comment
Author: Admin | 2025-04-28
The company agreed to pay $36 million in connection with the illegal promotion of Evista.2006: Lilly paid $700 million to settle around 8,000 lawsuits related to antipsychotic medication Zyprexa and, in early 2007, paid $500 million to settle around 18,000 other lawsuits.2006: Lilly bought Icos Corporation in order to gain full control of Cialis (tadalafil).2007: Evista, a drug that helps reduce the risk of invasive breast cancer, was introduced by the company after FDA approval.2008: The company acquired the cancer-drug maker ImClone Systems for $6.5bn.2008: Cialis, used to treat male sexual function problems, was launched by the company.2008: John C. Lechleiter was elected as Lilly’s CEO and president.2008: Eli Lilly purchased the right to manufacture controversial bovine growth hormone from Monsanto.2008: Sidney Taurel retired as CEO but remained as chairman of the board until 31 December.2009: Effient, a drug used to prevent blood clots in heart disease patients, was launched by the company.2009: Eli Lilly pleaded guilty to a US federal criminal misdemeanor charge of illegally marketing Zyprexa and paid a $1.415 billion penalty.2011: Lilly partnered with Boehringer Ingelheim to develop and market Tradjenta, which lowers blood sugar in adults with type 2 diabetes.2011: Zyprexa’s patent expired.2013: Cymbalta’s patent expired, which led to a large loss in sales.2013: Eli Lilly sued Canada for violating its obligations to foreign investors under NAFTA by allowing its courts to invalidate patents for Straterra and Zyprexa.2014: Jardiance and Trulicity were launched, which are drugs aimed at the treatment of type 2 diabetes.2014: Eli Lilly launches diabetes drug Trulicity (dulaglutide).2014: Lilly announced plans to buy Swiss drugmaker Novartis AG’s animal health business for $5.4 billion.2017: Lilly acquired CoLucid Pharmaceuticals for $960 million.2017: Lilly and Shionogi jointly licensed their product varespladib to Ophirex for the latter’s novel snakebite treatment program.2018: Lilly acquired Armo Biosciences for $1.6 billion.2019: The company debuted a generic version of Humalog to provide a lower-cost option.2019: Lilly announced it would acquire Loxo Oncology for around $8 billion.2019: Lawmakers from the United States House of Representatives sent letters to Eli Lilly and other insulin manufacturers asking for explanations for their rapidly raising insulin
Add Comment